Dear , 

We are delighted to announce the launch of the University of Cambridge Enterprise Fund V.

Managed in conjunction with Cambridge Enterprise, the University’s Technology Transfer Office, the Fund offers alumni, those associated with the university and investors the opportunity to invest in companies formed to commercialise scientific and technological discoveries made at the University of Cambridge, in a tax efficient manner through the Enterprise Investment Scheme.

Cambridge is Europe’s most productive technology cluster, having produced fifteen companies valued at more than $1 billion, of which two are valued at more than $10 billion. At the heart of the cluster sits the University of Cambridge, one of the top four Universities in the world.

There is more detail about the Fund on the Parkwalk website here and an overview of Cambridge Enterprise's activities in 2016 here.

There has been considerable interest in the Fund, and  the University of Cambridge Enterprise Funds I-IV closed in a short period of time after becoming over-subscribed.

The Fund will be relatively small, and therefore there is a possibility that investors' indications of interest and/or subscriptions may be scaled back.

Please reply or email ucef@parkwalkadvisors.com if you would like a copy of the prospectus.

This financial promotion is issued by Parkwalk Advisors Limited (Parkwalk), which is authorised and regulated by the Financial Conduct Authority. Investments referred to in this newsletter are not suitable for all investors.  Interested parties are strongly recommended to seek specialist financial and tax advice before investing in any product.  Capital is at risk and investors may not get back the full amount invested. Tax treatment depends on the individual circumstances of each investor and may be subject to change. Past performance is not a reliable indicator of future results, and the value of investments may go down as well as up. Projections and forecasts are also not a reliable indicator of future performance. Investments in small and unquoted companies carry a higher risk than many other forms of investment. Any investment in a Parkwalk product must only be made on the basis of the terms of the full Information Memorandum. Parkwalk is not able to provide advice as to the suitability of investing in any product.